David R. Little advises clients on complex UK, EU, and international competition law matters, including merger control, anticompetitive agreements, abuse of dominance, litigation, and sectoral regulation.
Mr. Little advises on a broad range of issues facing the media and entertainment, communications, technology, life sciences, financial services, and energy sectors. He regularly represents clients before the European Commission and the UK Competition and Markets Authority (CMA), and in litigation before the European Courts in Luxembourg and the UK High Court. He also has extensive experience appearing before administrative agencies outside of the EU and the UK.
Mr. Little was seconded to the UK CMA in 2015.
Mr. Little has published on areas of competition law including merger control, restrictive agreements, abuse of dominance, and state aid. He is the co-editor of the Getting the Deal Through - Dominance guide. David has also published on other areas of commercial law, including impact investment and sustainable finance.
Mr. Little’s representative experience includes advising:
- The Walt Disney Company in various EU and UK competition law matters, including its acquisition of 21st Century Fox, the European Commission’s investigation into the cross-border licensing of online content, and the UK Competition Commission’s investigation into the UK TV subscription market market*
- Complainants in European Commission proceedings against Microsoft concerning the interface between IP and competition law (e.g., disclosure of Microsoft interoperability information), leading to the 2009 Microsoft Interoperability Undertaking, the 2009 Microsoft Browser Choice Commitment, and related European Court judgments up to 2014*
- NVIDIA in an abuse of dominance complaint against Qualcomm, culminating in the European Commission’s first predatory pricing infringement decision in more than 15 years, and a related damages claim in the English High Court*
- Google in various matters, including its acquisitions of BeatThatQuote and Waze, and in the European Commission’s competition investigation of Google*
- Sony Corporation of America in various transactions, including the EU and international antitrust aspects of its US$2.2 billion acquisition of EMI Music Publishing and its acquisition of the 50% interest in Sony/ATV held by the Estate of Michael Jackson*
- GlaxoSmithKline in the global antitrust aspects of its multibillion-dollar, three-part transaction with Novartis, involving its consumer healthcare, vaccines, and oncology businesses*
- Medtronic in its US$49.9 billion acquisition of Covidien*
- The Dow Chemical Company in its US$130 billion all-stock merger of equals with DuPont*
- Airbus in its acquisition of the commercial aircraft division of Bombardier*
- Equant (a subsidiary of France Telecom) in obtaining an emergency restraining order from the President of the European Court of First Instances*
- Philips in connection with its defense against complaints alleging abuse of dominance in licensing LED technology*
- AbbVie in the EU antitrust aspects of itsUS$21 billion acquisition of Pharmacyclics*
- Warburg Pincus in various acquisitions, including its acquisition of Santander Asset Management, Santander’s custody and fund administration business, and Allfunds fund distribution platform*
- Merck & Co in its US$4 billion sale of Merial to Sanofi-aventis and on the animal health joint venture with Sanofi-aventis*
Matter handled prior to joining the firm